Hepatitis C Cooperative Research Centers (U19)

Post Date

April 7th 2009

Application Due Date

August 6th 2009

Funding Opportunity Number

RFA-AI-09-025

CFDA Number(s)

93.855
93.856

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $4000000

• Award Range:

  $None - $None

Grant Description

Purpose. The National Institute of Allergy and Infectious Diseases (NIAID) invites applications for Hepatitis C Cooperative Research Centers (HepC CRCs). These Centers will advance the understanding of hepatitis C virus (HCV)-host interactions, specifically the host immune response to infection, and the factors that tilt the balance between spontaneous or therapy-induced clearance and chronic persistence of HCV. Experimental observations will be validated and clinical relevance demonstrated, in appropriate, well-defined, patient cohorts. The underlying mission of the Centers is to close the gaps that currently exist with regard to defining successful immune response and identifying new targets for antiviral drugs, vaccines, and other therapeutic strategies for the prevention or treatment of acute and chronic HCV infection. Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH multi-project (U19) cooperative agreement grant mechanism. Funds Available and Anticipated Number of Awards. The NIAID expect(s) to award $4 million in total costs in response to this FOA, in FY 2010, to fund 4-5 new and/or renewal grants.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-09-025.html